Auteurs
Analysis
France
Racine
Analysis
France
Exploration
Accueil
Racine
Racine

Movement Disorders (revue) - Analysis (France)

Index « Auteurs » - entrée « Olivier Flabeau »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Olivier Cottencin < Olivier Flabeau < Olivier Fourcade  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 3.
Ident.Authors (with country if any)Title
000045 (2014) Olivier Flabeau [France] ; Wassilios G. Meissner ; Annaig Ozier ; Patrick Berger ; François Tison ; Pierre-Olivier FernagutBreathing variability and brainstem serotonergic loss in a genetic model of multiple system atrophy.
000075 (2013) Fanny Duval [France] ; Olivier Flabeau ; Julien Razafimahefa ; Umberto Spampinato ; François TisonEncephalophaty associated with rasagiline and sertraline in Parkinson's disease: possible serotonin syndrome.
000243 (2009) Olivier Flabeau [France] ; Wassilios Meissner [France] ; Alexandra Foubert-Samier [France] ; Dominique Guehl [France] ; Patrice Desbordes [France] ; François Tison [France]Opsoclonus myoclonus syndrome in the context of Salmonellosis

List of associated KwdEn.i

Nombre de
documents		Descripteur
3Humans
2Male
1Aged
1Akathisia, Drug-Induced (physiopathology)
1Animals
1Antiparkinson Agents (therapeutic use)
1Brain Diseases (etiology)
1Brain Stem (pathology)
1Delusions (chemically induced)
1Depressive Disorder, Major (complications)
1Depressive Disorder, Major (drug therapy)
1Disease Models, Animal
1Drug Interactions
1Drug Therapy, Combination
1Female
1Inclusion Bodies (pathology)
1Indans (adverse effects)
1Indans (therapeutic use)
1Mice, Inbred C57BL
1Middle Aged
1Models, Genetic
1Multiple System Atrophy (genetics)
1Multiple System Atrophy (pathology)
1Multiple System Atrophy (physiopathology)
1Myoclonus
1Myoclonus (chemically induced)
1Myoclonus (physiopathology)
1Nervous system diseases
1Neurons (pathology)
1Neuroprotective Agents (adverse effects)
1Neuroprotective Agents (therapeutic use)
1Opsoclonus
1Opsoclonus-Myoclonus Syndrome (etiology)
1Opsoclonus-Myoclonus Syndrome (microbiology)
1Parkinson Disease (complications)
1Parkinson Disease (drug therapy)
1Respiration
1Salmonella Infections (complications)
1Salmonellosis
1Serotonin Syndrome (etiology)
1Serotonin Syndrome (physiopathology)
1Serotonin Uptake Inhibitors (adverse effects)
1Serotonin Uptake Inhibitors (therapeutic use)
1Sertraline (adverse effects)
1Sertraline (therapeutic use)

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/France/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "Olivier Flabeau" 

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i  \
                -Sk "Olivier Flabeau" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Olivier Flabeau
}}
Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024